Sort by
Refine Your Search
-
NIST only participates in the February and August reviews. Research on photovoltaics focuses on the development of new and improved device characterization methods for various cell technologies and
-
of materials under operational conditions improves fundamental understanding and accelerates development of highly-reliable materials and devices. Applicants will work to develop relevant test approaches
-
microfluidic networks.Our goal is to develop systems that enable accurate, high-throughput, and dynamic measurement of materials in flow, which will, for example, improve the ability to specify composition and
-
, but face technical challenges to achieve their potential for high efficiency. Third generation devices are now being developed that exploit nanoscale three-dimensional (3D) structures to achieve higher
-
Development of magnetism-based future electronics is fueled by demand for large memory capacity and high data processing rates. New technologies such as hard drives with bit-patterned media and magnetic memory
-
group is working to develop the measurement science and technology to make multiplexed biomolecular measurements practical, while also working to develop the standards and measurement assurance approaches
-
determination of marijuana components, development of vapor measurement technology and canine training aid materials for opioids and improvised explosives, targeted and non-targeted screening of bulk samples and
-
prevent a true function-by-design approach to development and manufacturing. We are interested in using analytical theory, large-scale molecular dynamics (MD) simulations, and density functional theory (DFT
-
) to develop a high-throughput technique to screen new materials for high frequency performance. As a first step, the Associate will focus on ferroelectric materials and transition metal dichalcogenides
-
Description The goals of this project are to develop new assays to support the production of safe and effective protein therapeutics. The new generations of biopharmaceuticals are produced using cells in